Cargando…

Prevalence and Mortality of Individuals With X-Linked Hypophosphatemia: A United Kingdom Real-World Data Analysis

BACKGROUND: X-linked hypophosphatemia (XLH) is a rare multisystemic disease with a prominent musculoskeletal phenotype. We aim here to improve understanding of the prevalence of XLH across the life course and of overall survival among people with XLH. METHODS: This was a population-based cohort stud...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hawley, Samuel, Shaw, Nick J, Delmestri, Antonella, Prieto-Alhambra, Daniel, Cooper, Cyrus, Pinedo-Villanueva, Rafael, Javaid, M Kassim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Clinical Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7025948/ https://www.ncbi.nlm.nih.gov/pubmed/31730177 http://dx.doi.org/10.1210/clinem/dgz203

Ejemplares similares

Musculoskeletal Features in Adults With X-linked Hypophosphatemia: An Analysis of Clinical Trial and Survey Data
por: Javaid, Muhammad Kassim, et al.
Publicado: (2021)

Health-related quality of life and a cost-utility simulation of adults in the UK with osteogenesis imperfecta, X-linked hypophosphatemia and fibrous dysplasia
por: Forestier-Zhang, Lydia, et al.
Publicado: (2016)

Encounters for foot and ankle pain in UK primary care: a population-based cohort study of CPRD data
por: Ferguson, Rachel, et al.
Publicado: (2019)

Bariatric surgery increases the rate of major fracture: self‐controlled case series study in UK Clinical Practice Research Datalink
por: Robinson, Danielle E., et al.
Publicado: (2021)

The impact of rheumatoid arthritis on the risk of adverse events following joint replacement: a real-world cohort study
por: Burn, Edward, et al.
Publicado: (2018)

Patient-reported outcomes measures of X-linked hypophosphataemia participants: findings from a prospective cohort study in the UK
por: Cole, Sophie, et al.
Publicado: (2023)

Estimating the Incidence and Key Risk Factors of Cardiovascular Disease in Patients at High Risk of Imminent Fracture Using Routinely Collected Real‐World Data From the UK
por: Pineda‐Moncusí, Marta, et al.
Publicado: (2022)

Comparative anti-fracture effectiveness of different oral anti-osteoporosis therapies based on “real-world” data: a meta-analysis of propensity-matched cohort findings from the UK Clinical Practice Research Database and the Catalan SIDIAP Database
por: Khalid, Sara, et al.
Publicado: (2018)

Clinical effectiveness of orthogeriatric and fracture liaison service models of care for hip fracture patients: population-based longitudinal study
por: Hawley, Samuel, et al.
Publicado: (2016)

Dental management of patients with X-linked hypophosphatemia
por: Lee, Bin-Na, et al.
Publicado: (2017)

Growth Curves for Children with X-linked Hypophosphatemia
por: Mao, Meng, et al.
Publicado: (2020)

Enthesopathy, Osteoarthritis, and Mobility in X-linked Hypophosphatemia
por: Imel, Erik A
Publicado: (2020)

Genotype and Phenotype Analysis in X-Linked Hypophosphatemia
por: Park, Peong Gang, et al.
Publicado: (2021)

Impact of X-Linked Hypophosphatemia on Muscle Symptoms
por: Romagnoli, Cecilia, et al.
Publicado: (2022)

Risk of adverse events following the initiation of antihypertensives in older people with complex health needs: a self-controlled case series in the United Kingdom
por: Jödicke, Annika M, et al.
Publicado: (2023)

Trends and determinants of length of stay and hospital reimbursement following knee and hip replacement: evidence from linked primary care and NHS hospital records from 1997 to 2014
por: Burn, Edward, et al.
Publicado: (2018)

Autism and X-linked hypophosphatemia: A possible association?
por: Joël, Vermeersch, et al.
Publicado: (2010)

SUN-526 Prevalence of Hyperparathyroidism in X-Linked Hypophosphatemia
por: DeLacey, Sean, et al.
Publicado: (2019)

X-Linked Hypophosphatemia: A New Era in Management
por: Dahir, Kathryn, et al.
Publicado: (2020)

X-linked Hypophosphatemia (XLH) Mimicking Rheumatic Disease
por: Takase, Ryosuke, et al.
Publicado: (2020)

Burosumab and Dental Abscesses in Children With X‐Linked Hypophosphatemia
por: Gadion, Margaux, et al.
Publicado: (2022)

Craniosynostosis in Patients With X‐Linked Hypophosphatemia: A Review
por: Munns, Craig F, et al.
Publicado: (2023)

Oral Bisphosphonates Are Associated With Increased Risk of Severe Acute Kidney Injury in Elderly Patients With Complex Health Needs: A Self‐Controlled Case Series in the United Kingdom
por: Oda, Tetsuro, et al.
Publicado: (2022)

One- and 2-year incidence of osteoporotic fracture: a multi-cohort observational study using routinely collected real-world data
por: Khalid, Sara, et al.
Publicado: (2021)

Increased prevalence of overweight and obesity in children with X-linked hypophosphatemia
por: Zhukouskaya, Volha V, et al.
Publicado: (2020)

Phenotypic characterization of X-linked hypophosphatemia in pediatric Spanish population
por: Rodríguez-Rubio, Enrique, et al.
Publicado: (2021)

Consensus Recommendations for the Diagnosis and Management of X-Linked Hypophosphatemia in Belgium
por: Laurent, Michaël R., et al.
Publicado: (2021)

Erratum to: “X-Linked Hypophosphatemia: A New Era in Management”
Publicado: (2021)

Serum Levels of Lipocalin Are Lower in Adolescents With X-Linked Hypophosphatemia
por: Simpson, Christine A, et al.
Publicado: (2021)

Health-related quality of life of X-linked hypophosphatemia in Spain
por: Yanes, M. I. Luis, et al.
Publicado: (2022)

Ossification of the Posterior Longitudinal Ligament Caused by X-linked Hypophosphatemia
por: Yamamoto, Koichiro, et al.
Publicado: (2023)

Burosumab for X-linked hypophosphatemia in children and adolescents: Opinion based on early experience in seven European countries
por: Mughal, M. Zulf, et al.
Publicado: (2023)

Unplanned admissions for patients with myeloma in the UK: Low frequency but high costs
por: Kolovos, Spyros, et al.
Publicado: (2019)

Secular trends in the initiation of therapy in secondary fracture prevention in Europe: a multi-national cohort study including data from Denmark, Catalonia, and the United Kingdom
por: Skjødt, M. K., et al.
Publicado: (2020)

Association between bisphosphonate use and implant survival after primary total arthroplasty of the knee or hip: population based retrospective cohort study
por: Prieto-Alhambra, Daniel, et al.
Publicado: (2011)

Burosumab in X-linked hypophosphatemia: a profile of its use in the USA
por: Lyseng-Williamson, Katherine A.
Publicado: (2018)

FGF23 and its role in X-linked hypophosphatemia-related morbidity
por: Beck-Nielsen, Signe Sparre, et al.
Publicado: (2019)

Correction to: Phenotypic characterization of X-linked hypophosphatemia in pediatric Spanish population
por: Rodríguez-Rubio, Enrique, et al.
Publicado: (2021)

Clinical and Genetic Characteristics of 153 Chinese Patients With X-Linked Hypophosphatemia
por: Lin, Xiaoyun, et al.
Publicado: (2021)

Corrigendum: Consensus Recommendations for the Diagnosis and Management of X-Linked Hypophosphatemia in Belgium
por: Laurent, Michaël R., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ik0j7mtat60jmd7unbi91avm6e